NCT05633719View on ClinicalTrials.gov

Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

December 1, 2023

Study Completion Date

June 30, 2026

Conditions
Solid Tumor, Childhood
Interventions
OTHER

Chemotherapy involving cisplatin or carboplatin

Chemotherapy

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT05633719 - Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer | Biotech Hunter | Biotech Hunter